Evolife Pharmaceuticals Private Limited
About Evolife Pharmaceuticals Private Limited
Data last updated:
Evolife Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2019PTC354129. Its GSTIN is 07AAFCE6106M1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nandini Vidyarthi and Vaishali Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 1/100 G/F Old No.198/1 Gali No. 2 Shri Ram Nagar Near Water Tank, Delhi, India – 110032.
As per the financials filed for FY 2024, the company reported a revenue of ₹20,060, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹11,167 (net margin -55.7%) and EBITDA of -₹9,161 (EBITDA margin -45.7%).
Company details
Contact details
Evolife Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH.No 1/100 G/F Old No.198/1 Gali No. 2 Shri Ram Nagar Near Water Tank, Delhi, India – 110032
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Evolife Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evolife Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Evolife Pharmaceuticals Private Limited, buy the company report.
Financials of Evolife Pharmaceuticals Private Limited
FY 2025 filings availableEvolife Pharmaceuticals Private Limited reported revenue of ₹20,060 (down 76% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 76% in the latest year. EBITDA fell 520% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9,161 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11,167 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -45.7% | ||||
| Net Profit Margin | -55.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evolife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Evolife Pharmaceuticals Private Limited
Evolife Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandini Vidyarthi | Director | 22 Aug 2019 | 7 Years 2 Months | Current |
| Vaishali Gupta | Director | 22 Aug 2019 | 7 Years 2 Months | Current |
| Vinay Kumar Pathak | Director | 18 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Evolife Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocius Pharmaceuticals Private Limited | ₹20,469 (FY 2025) | -58.0% | Harinagar, Delhi, India | |||
| Zanexo Pharmaceuticals Private Limited | ₹20,232 (FY 2025) | -95.0% | Chennai, Tamil Nadu, India | |||
| Evolife Pharmaceuticals Private Limitedthis company | ₹20,060 (FY 2024) | -₹11,167 | -55.7% | -76.0% | Delhi, India | |
| KML Pharmaceuticals Private Limited | ₹20,000 (FY 2022) | 33.0% | Samastipur, Bihar, India |
To see the full peer comparison of Evolife Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Evolife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evolife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Evolife Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCE6106M1ZJ | Delhi | Active | 09 Nov 2019 |
To see the full GST registrations and return filing status of Evolife Pharmaceuticals Private Limited, buy the company report.
Recent activity
Evolife Pharmaceuticals Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Krishna Kumar ceased to be Director on 20 Aug 2024.
Frequently asked questions
Evolife Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 August 2019 (7+ years old) and is registered under CIN U24110DL2019PTC354129.
Evolife Pharmaceuticals has 3 current directors:
- Nandini Vidyarthi - Director
- Vaishali Gupta - Director
- Vinay Kumar Pathak - Director
The latest financial statements of Evolife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Evolife Pharmaceuticals is 07AAFCE6106M1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Evolife Pharmaceuticals is U24110DL2019PTC354129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evolife Pharmaceuticals was incorporated on 22 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Evolife Pharmaceuticals by revenue are Biocius Pharmaceuticals Private Limited, Zanexo Pharmaceuticals Private Limited, KML Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Krishna Kumar ceased to be Director on 20 Aug 2024. Vinay Kumar Pathak was appointed as Director on 18 Oct 2019. Nandini Vidyarthi was appointed as Director on 22 Aug 2019. Evolife Pharmaceuticals has 4 board changes on record in total.
The registered office of Evolife Pharmaceuticals is at H.No 1100 GF Old No.1981 Gali No. 2 Shri Ram Nagar Near Water Tank, Delhi, India – 110032.
Evolife Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Evolife Pharmaceuticals can be reached at its registered office: H.No 1100 GF Old No.1981 Gali No. 2 Shri Ram Nagar Near Water Tank, Delhi, India – 110032.